The US Food and Drug Administration has reopened until 7 September the public comment period for its proposal to lower the classification of certain neurological and physical medicine devices from Class III (high-risk) to Class II (medium-risk)1,2.
The initial comment period on the proposed rule and related draft guidance3,4 ended on 6 July but the FDA has agreed to requests for additional time from interested parties...
Please login to read the full article.
